Key points are not available for this paper at this time.
Low-risk patients had estimates of 5-year PSA outcome after treatment with RP, RT, or implant with or without neoadjuvant androgen deprivation that were not statistically different, whereas intermediate- and high-risk patients treated with RP or RT did better then those treated by implant. Prospective randomized trials are needed to verify these findings.
Building similarity graph...
Analyzing shared references across papers
Loading...
Anthony V. D’Amico (Wed,) studied this question.
www.synapsesocial.com/papers/69dcd241e3a90a2e2f133304 — DOI: https://doi.org/10.1001/jama.280.11.969
Anthony V. D’Amico
JAMA
Harvard University
Building similarity graph...
Analyzing shared references across papers
Loading...
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: